Surveillance of multidrug-resistant tuberculosis in Taiwan, 2008–2019
Authors:
Open Access
- 11 August 2022
- journal article
- research article
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 56 (1) , 120-129
Abstract
No abstract availableKeywords
Funding Information
- World Health Organization
- Ministry of Health and Welfare
This publication has 22 references indexed in Scilit:
- Analysis of embCAB Mutations Associated with Ethambutol Resistance in Multidrug-Resistant Mycobacterium tuberculosis Isolates from ChinaAntimicrobial Agents and Chemotherapy, 2015
- On the spread and control of MDR-TB epidemics: An examination of trends in anti-tuberculosis drug resistance surveillance dataDrug Resistance Updates, 2014
- Profiling of rpoB Mutations and MICs for Rifampin and Rifabutin in Mycobacterium tuberculosisJournal of Clinical Microbiology, 2014
- Epidemiology of Pyrazinamide-Resistant Tuberculosis in the United States, 1999–2009Clinical Infectious Diseases, 2013
- Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in TaiwanJournal of Antimicrobial Chemotherapy, 2013
- Drug Resistance Pattern of Mycobacterium Tuberculosis Complex at a Medical Center in Central Taiwan, 2003–2007Journal of Microbiology, Immunology and Infection, 2010
- Extensively Drug‐ResistantMycobacterium tuberculosisduring a Trend of Decreasing Drug Resistance from 2000 through 2006 at a Medical Center in TaiwanClinical Infectious Diseases, 2008
- Extensively Drug-Resistant Tuberculosis,TaiwanEmerging Infectious Diseases, 2008
- A Minimum 5.0 ml of Sputum Improves the Sensitivity of Acid-fast Smear for Mycobacterium tuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Drug-Resistant Tuberculosis: Review of the Worldwide Situation and the WHO/IUATLD Global Surveillance ProjectClinical Infectious Diseases, 1997